Distribution of ZPI haplotypes among patients with venous thrombosis and control subjects
. | Patients, no. (% or frequency) . | Controls, no. (% or frequency) . |
|---|---|---|
| H1/H1 (reference group) | 297 (29.2) | 328 (32.2) |
| H1/H2 | 337 (33.1) | 334 (32.8) |
| H1/H3 | 163 (16.0) | 182 (17.9) |
| H1/H4 | 3 (0.3) | 4 (0.4) |
| H1/H5 & H1/H5v | 17 & 1 (1.8) | 5 (0.5)* |
| H2/H2 | 90 (8.8) | 83 (8.1) |
| H2/H3 | 77 (7.6) | 66 (6.5) |
| H2/H4 | 5 (0.5) | 1 (0.1) |
| H2/H5 | 9 (0.9) | 3 (0.3) |
| H3/H3 | 13 (1.3) | 11 (1.1) |
| H3/H4 | 3 (0.3) | 0 |
| H3/H5 | 2 (0.2) | 1 (0.1) |
| H5/H5 | 1 (0.1) | 0 |
| H1 (reference group) | 1115 (0.546) | 1181 (0.580) |
| H2 | 608 (0.299) | 570 (0.280) |
| H3 | 271 (0.134) | 271 (0.133) |
| H4 | 11 (0.006) | 5 (0.003) |
| H5 & H5v | 30 & 1 (0.015 & 0.0005) | 9 & 0 (0.004)* |
. | Patients, no. (% or frequency) . | Controls, no. (% or frequency) . |
|---|---|---|
| H1/H1 (reference group) | 297 (29.2) | 328 (32.2) |
| H1/H2 | 337 (33.1) | 334 (32.8) |
| H1/H3 | 163 (16.0) | 182 (17.9) |
| H1/H4 | 3 (0.3) | 4 (0.4) |
| H1/H5 & H1/H5v | 17 & 1 (1.8) | 5 (0.5)* |
| H2/H2 | 90 (8.8) | 83 (8.1) |
| H2/H3 | 77 (7.6) | 66 (6.5) |
| H2/H4 | 5 (0.5) | 1 (0.1) |
| H2/H5 | 9 (0.9) | 3 (0.3) |
| H3/H3 | 13 (1.3) | 11 (1.1) |
| H3/H4 | 3 (0.3) | 0 |
| H3/H5 | 2 (0.2) | 1 (0.1) |
| H5/H5 | 1 (0.1) | 0 |
| H1 (reference group) | 1115 (0.546) | 1181 (0.580) |
| H2 | 608 (0.299) | 570 (0.280) |
| H3 | 271 (0.134) | 271 (0.133) |
| H4 | 11 (0.006) | 5 (0.003) |
| H5 & H5v | 30 & 1 (0.015 & 0.0005) | 9 & 0 (0.004)* |
Statistical comparison versus reference group P < .01.